SCHEMBL4152252

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL4147368	1.00	AR (0.50)	ARP2RY12UBE2MDCUN1D1SCN9A
	SCHEMBL4138383	0.91	AR (0.48)	ARUBE2MDCUN1D1SCN9A
	SCHEMBL4132662	0.91	AR (0.47)	ARUBE2MDCUN1D1
	SCHEMBL4133498	0.91	AR (0.47)	ARUBE2MDCUN1D1
	SCHEMBL4141069	0.90	AR (0.47)	AR
	SCHEMBL4136182	0.89	AR (0.50)	ARP2RY12SCN9A
	SCHEMBL4133470	0.86	AR (0.47)	ARP2RY12
	SCHEMBL4138070	0.85	AR (0.45)	AR
	SCHEMBL4139756	0.85	AR (0.46)	ARUBE2MDCUN1D1
	SCHEMBL13771921	0.85	AR (0.48)	ARUBE2MDCUN1D1SCN9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.